KBC Group NV Has $176.10 Million Holdings in Cigna Group $CI

KBC Group NV trimmed its position in shares of Cigna Group (NYSE:CI) by 1.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 532,693 shares of the health services provider’s stock after selling 6,808 shares during the quarter. KBC Group NV’s holdings in Cigna Group were worth $176,097,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Retirement Systems of Alabama increased its position in Cigna Group by 3.9% during the second quarter. Retirement Systems of Alabama now owns 165,487 shares of the health services provider’s stock worth $54,707,000 after buying an additional 6,155 shares during the last quarter. Modern Wealth Management LLC increased its holdings in shares of Cigna Group by 91.3% during the 1st quarter. Modern Wealth Management LLC now owns 3,130 shares of the health services provider’s stock valued at $1,030,000 after acquiring an additional 1,494 shares during the last quarter. Janney Montgomery Scott LLC raised its stake in shares of Cigna Group by 3.9% in the 2nd quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider’s stock valued at $11,882,000 after acquiring an additional 1,357 shares in the last quarter. Acadian Asset Management LLC lifted its holdings in Cigna Group by 277.5% in the 1st quarter. Acadian Asset Management LLC now owns 8,274 shares of the health services provider’s stock worth $2,718,000 after purchasing an additional 6,082 shares during the last quarter. Finally, Pzena Investment Management LLC grew its holdings in Cigna Group by 9.7% during the second quarter. Pzena Investment Management LLC now owns 523,600 shares of the health services provider’s stock valued at $173,092,000 after purchasing an additional 46,140 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Up 3.7%

NYSE CI opened at $267.82 on Wednesday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company has a market capitalization of $71.54 billion, a price-to-earnings ratio of 14.62, a PEG ratio of 0.88 and a beta of 0.44. The stock’s 50 day moving average is $291.71 and its two-hundred day moving average is $302.28. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping the consensus estimate of $7.64 by $0.19. The business had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.Cigna Group’s revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the company earned $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a $1.51 dividend. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio is presently 26.64%.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Jefferies Financial Group reiterated a “buy” rating and issued a $310.00 target price on shares of Cigna Group in a report on Monday, November 3rd. Robert W. Baird set a $372.00 price objective on Cigna Group in a research report on Thursday, August 14th. The Goldman Sachs Group lowered their target price on Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a report on Tuesday, November 4th. Leerink Partners cut their price target on Cigna Group from $300.00 to $270.00 in a report on Friday, October 31st. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Cigna Group in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $339.73.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by insiders.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.